AGP Executive Report

Cannabis Policy & Public Health: A new systematic review finds cannabis legalization can raise young-adult use and, in some studies, increase ER visits and poison center reports—while effects vary by age and policy. Medical Cannabis Access: Illinois approved 37 adult-use dispensaries to also sell medical cannabis, aiming to boost patient access and cut regulatory friction. Cannabis Market Watch: ASX-listed Avecho says its big cannabidiol insomnia trial cleared to fully enroll, with patent allowances and a generics licensing deal supporting an eventual pharmacy OTC sleep product. Clinical/Research: Evidence links inflammatory bowel disease with higher risk of psychiatric disorders, adding to the growing picture of mental health comorbidity. Safety & Use Concerns: A California case alleges a deputy choked his 5-year-old son after a breakfast-time dispute, underscoring how family crises can escalate alongside drug-related scrutiny. Local Enforcement: Police in Siberia Mines report a marijuana haul of about 78 pounds after a motorcycle chase.

Regulated Market Watch: Illinois is letting 37 existing adult-use dispensaries add medical cannabis sales under new omnibus law, aiming to boost patient access while cutting red tape. Medical Access & Community: A Florida nonprofit is offering free medical marijuana evaluations to 250 veterans across multiple cities, covering card costs for qualifying participants. CBD & Sports: A new review says CBD may help with post-exercise soreness and muscle damage markers, but doesn’t appear to improve performance—plus a reminder that mislabeled products could risk anti-doping issues. Public Health Alert: An ER doctor warns that cannabis edibles are driving a sharp rise in accidental ingestions among kids under 6, urging tighter home safety. Legal/Enforcement: A man in Melbourne pleaded guilty after police found 269 cannabis plants (189kg) in a “sophisticated” setup. Industry/Branding: Kendall Jenner bought into Trip, a calming drinks brand infused with CBD (and magnesium/adaptogens), as it targets major revenue growth. Patient Experience: New Orleans opened its first French Quarter dispensary, touting telehealth doctor consults for medical cards. Research Roundup: Teens playing a behavioral health video game showed improved depressive symptoms and more positive views on psychological services.

Child Safety: A CNN report warns that cannabis edibles are driving a sharp rise in accidental ingestions among kids under 6, urging parents to treat home storage like a poison-safety issue. Public Health + Caregiving: New survey findings show 7 in 10 people say a loved one’s chronic condition harms their mental health, with many caregivers feeling guilt, anxiety, and sleep strain—highlighting the need for better support systems. Veterinary CBD/Anxiety: A pet-wellness piece discusses storm anxiety and notes that vets may consider meds like trazodone or gabapentin, while CBD quality varies and should be chosen carefully. Hemp Policy Shock: Missouri businesses are bracing as a state law will reclassify intoxicating hemp-THC products as marijuana, pushing sales into licensed dispensaries. Local Enforcement: Norwood, Massachusetts moves to ban kratom and synthetic cannabinoids under a board of health rule aimed at reducing harm from unregulated psychoactive products. Industry/Research: EPIK Biosciences touts progress on ketamine-based and DXM-based combination medicines across depression, anxiety, PTSD, pain, and substance use. Medical Cannabis Politics: Wisconsin candidates clash over marijuana legalization vs a medical program, while hemp firms worry about a looming federal ban.

Hemp/CBD Policy Pressure: Kentucky hemp businesses say a looming federal ban could be the “first nail in the coffin,” warning that tight rules would wipe out CBD options many customers use for pain, sleep, anxiety, and “harm reduction.” Local Health Regulation: Massachusetts crackdown widens as Norwood moves to ban kratom and synthetic cannabinoids (like delta-8/delta-10) under local board-of-health rules aimed at keeping unregulated psychoactive products out of town. Product/Research Watch: Trait Biosciences reports new preclinical findings that its water-soluble CBD82S™ (and native CBD) shows up in brain tissue after topical use, pointing to more sustained brain availability. Public Health & Care Access: Vitalant is running blood drives across Northern California in September, stressing steady platelet and type O blood donations for cancer patients. Community & Mental Health: A Guam mental health conference highlights how marketing, flavors, and easy access drive nicotine/vape use in minors—plus the role of peer influence. Cannabis in the Courts/Enforcement: A record-scale Peru cannabis seizure case keeps moving, with suspects ordered held as prosecutors argue the quantity is trafficking-level. Wellness/Everyday Guidance: A sleep piece notes cannabis/THC may help people fall asleep faster but can reduce REM sleep.

Medical Cannabis Integration: Avicanna launched MyMedi.ca’s Integrated Healthcare Program in Canada, aiming to plug medical cannabis care into hospitals and clinical networks with pharmacist-led support, provider planning, and reimbursement pathways. Hemp THC Policy Shock: Missouri’s hemp-THC beverage makers are bracing for a looming federal ban after a one-month delay, with some planning to pivot back toward CBD-style products. Regulatory/Market Watch: Intelligent Bio Solutions filed an FDA 510(k) package for its Intelligent Fingerprinting Drug Screening System to detect codeine, targeting U.S. drug screening clearance. Enforcement & Smuggling: India arrested a Malaysian woman at Delhi airport after 15kg of cannabis was found in her trolley bag; separately, Nepal police seized 1,240.6kg of banned marijuana after a truck driver fled a checkpoint. Public Health Angle: Baltimore urged safe sleep for infants, warning that smoke or vaping—including marijuana—around babies is dangerous for their lungs. Industry Growth (Cancer): A cancer vaccines market report projects growth to $31.13B by 2035, driven by HPV mandates and mRNA platform progress.

Hemp Policy Shake-Up: The U.S. House passed a budget bill delaying the federal hemp-derived THC crackdown from Nov. 12 to Dec. 11, but Texas’ stricter Schedule I-style ban on most hemp THC products still stands, leaving consumers in a legal gray zone. Courtroom Stakes: A federal appeals fight over marijuana rescheduling could swing billions in tax benefits, with claims that Schedule III treatment hinges on state-licensed products that aren’t FDA-approved. Regulation Pressure: A National Agricultural Law Center analysis says the industry is racing to agree on hemp testing rules before the delay expires, while lawmakers push alternative regulatory frameworks. Medical & Safety Watch: Baltimore is urging safe sleep after 11 sleep-related infant deaths in 2026, noting risks from smoking or vaping—including marijuana—around babies. Product & Market Moves: A new THC grape drink launch targets High Holy Days, while LIX Pet Wellness rolls out a CBD/CBG/CBN cat formula. Enforcement & Crime: Texas police arrested a Lubbock man after finding 133 pounds of marijuana and cash in a truck; in the UK, a Liverpool case ended in a cocaine sentence after a suitcase smuggling plot. Research Signals: A lab study suggests common vaping additives (including CBD) can soften lung surfactant at high concentrations, raising caution calls.

CBD & Policy: Medicare is rolling out a pilot covering hemp-derived CBD for certain patients, even as Congress moves toward wiping many hemp CBD products off the market—leaving patients and businesses stuck in a policy tug-of-war. Caregiver Mental Health: A Curaleaf Clinic survey finds 7 in 10 carers say a loved one’s chronic illness has harmed their own mental health, with anxiety, isolation, and lost personal time topping the list. CBD Brand Spotlight: Kendall Jenner is taking an equity stake in Trip, a UK CBD drinks and supplements company, and will front a new global campaign. Addiction Telehealth: Quel Health launched as the first national telehealth company built around GLP-1s for addiction, partnering with Caron Treatment Centers. Cannabis Enforcement Abroad: Hong Kong Customs seized 6.1 tons of drugs in a major airport operation, including cannabis, with 150 arrests. Medical Cannabis Access (US): Talladega, Alabama opened a new medical cannabis dispensary to expand access for qualifying patients.

ASX Cannabis Pharma Watch: Neurotech International (ASX:NTI) is pushing a standardized, low-THC cannabinoid autism programme through conventional pharma steps, with a US clearance opening a parallel dosing study as recruitment ramps up. Clinical Trial Checkpoint: Avecho (ASX:AVE) got an independent monitoring board thumbs-up to continue its pivotal CBD insomnia trial at the planned size, restarting final-stage recruitment and supported by a global generics licence deal. Clinic Rollout: Emyria (ASX:EMD) keeps expanding its Empax clinic network across mainland states, with NSW training completed ahead of the next site opening and a reimbursement pathway via private insurance. Policy & Regulation: A Colombian medicinal cannabis policy effort is getting a detailed “evidence-to-decision” roadmap, aiming to close the science-to-rules gap for access, THC limits, and clinician training. Hemp THC Retail: Convenience stores are celebrating a federal delay on hemp THC restrictions, arguing for regulation over prohibition. Public Health Note: A Cleveland dispatcher faces child endangerment charges after her child tested positive for marijuana.

CBD for pets: Votum Labs’ SOS by Happy Pets launched a CBD calming spray for fireworks and travel, claiming THC-free formulas and non-sedating calm for anxious dogs and cats. Cannabis policy fight: North Carolina’s hemp-derived THC industry is getting squeezed as advocacy group CBHD pushes back on federal THC-threshold changes, with Winston-Salem feeling the impact. Hemp THC crackdown delay: Multiple reports point to federal hemp THC restrictions being paused, shifting the “ban” timeline and raising stakes for state regulators and retailers. Medical cannabis access model: Utah’s pharmacy-style medical cannabis program (pharmacist consults, cannabis-only dispensing) is being framed as a blueprint for a future Schedule III system. Health debate: A new study links cannabis use disorder with a higher lung cancer risk, reigniting the “smoke vs. evidence” argument. Enforcement headlines: Large cannabis seizures and arrests continue across the US and abroad, including a major haul near Yass and big interstate seizures. Road safety: Coroner findings in a fatal crash cite meth and also flag cannabis in the driver’s system. Texas legal risk: Delta-8 THC gummies may carry felony exposure in Texas as federal and state rules tighten around edible THC weight.

Hemp Policy Clash (US): A Virginia federal judge is being asked to slow a state law that effectively tightens hemp product sales by removing the old 25-to-1 CBD-to-THC ratio, with the lawsuit arguing it violates constitutional protections for hemp products sold across the state. Hemp THC Crackdown (US): Texas is facing fresh legal risk for delta-8 and other hemp-derived THC gummies after changes to how THC is classified and counted by total edible weight, with a single small gummy potentially triggering felony-level penalties. Medical Cannabis Retail Model (Utah): Utah’s medical cannabis pharmacies are being highlighted as a “pharmacy instead of dispensary” approach, requiring a licensed pharmacist to consult patients on dosing, delivery, and interactions. Hemp Advocacy (North Carolina): A North Carolina hemp coalition is pushing back on federal pressure that could reshape local rules, with Winston-Salem positioned as a key battleground for hemp-derived cannabinoid policy. Road Safety + Cannabis (NZ): A coroner found a meth-using driver’s crash was likely driven by speed, fatigue, emotional distress, and intoxication, while noting cannabis showed up in the other driver—raising concerns for lawmakers and road users. Cannabis Seizures (Global): Authorities report major cannabis busts, including a large I-80 seizure in Peru and multiple drug operations tied to “Indian hemp” in Nigeria.

Hemp THC court fight: A federal judge in Roanoke is being asked to slow Virginia’s hemp law after a lawsuit argues the state is effectively taking property without compensation, targeting hemp products sold through the “hemp channel” and the THC limits that were meant to keep them from getting too intoxicating. Cannabis in the spotlight: At the U.S. Open, Aryna Sabalenka briefly halted play after complaining about a strong weed smell, sparking a wave of online debate and jokes. CBD for pain shoppers: A UK retailer is promoting Kloris CBD Comfort Balm (800mg CBD per jar) with customer claims of reduced joint pain and improved mobility. Public health watch: Hong Kong health officials are investigating a confirmed mpox case and urging high-risk groups to get vaccinated, while customs also seized about 12kg of cannabis buds at the airport. Drug harm reminders: Idaho’s fentanyl case coverage highlights how overdose-related help can be treated harshly under state trafficking rules, underscoring the stakes around fentanyl risk.

Hemp THC policy shake-up: Congress approved a one-month delay of the federal hemp THC restrictions, keeping the industry in limbo while lawmakers debate whether regulation or prohibition is next. Regulatory enforcement: California moved to remove thousands of illegal hemp/kratom/7-OH products from store shelves, signaling tighter oversight. CBD for pain claims: A shopper praised a CBD Comfort Balm (800mg CBD plus CBG and plant butters) for helping severe joint pain and mobility. Cannabis and driving risk: An Elgin woman was convicted after testing showed THC levels about seven times the legal limit while driving with her teenage son. Public health & outbreaks: Hong Kong is investigating a confirmed mpox case and urged high-risk groups to get vaccinated. Drug harms spotlight: A Utah man was sentenced to 12+ years for distributing fentanyl that led to a death, underscoring ongoing overdose risks. Sports culture moment: Aryna Sabalenka paused a US Open match after complaining about a strong weed smell in the stands.

Hemp THC policy shake-up: The U.S. House passed a short-term funding bill that pushes the federal hemp THC restrictions back about a month, giving the industry a brief reprieve while lawmakers scramble over what comes next. Public health & enforcement: Hong Kong’s CHP is investigating a confirmed mpox case and urging high-risk groups to get vaccinated, while Hong Kong Customs seized about 12kg of cannabis buds at the airport and arrested three passengers. Cannabis in the spotlight (sports): Aryna Sabalenka briefly halted her U.S. Open match after complaining about a strong weed smell in the stands, sparking a wave of online reactions. Local harm-reduction debate: Quincy, Massachusetts-area officials discussed banning kratom sales after poison-control and death concerns, highlighting how “natural” products can still pose serious risks. Legal system pressure: Nigeria’s Jos University Teaching Hospital reported psychiatric bed shortages as mental health demand rises, with families waiting in emergency units. Court & custody headlines: A Wyoming driver was convicted after testing seven times over the legal cannabis limit while her son was in the car.

Hemp THC Policy: Lawmakers are debating how to regulate hemp-derived THC products after Trump signed a bill delaying the federal recriminalization deadline from November 12 to December 11, with some pushing alcohol-style rules and others still aiming for a full ban. Criminal Justice & Cannabis: Former Alabama player Darius Miles faces new jail-related charges after staff allegedly found “paper route” synthetic marijuana in his property while he awaits trial for a 2023 capital murder case. Public Safety & Kratom: Quincy, Nebraska-area officials discussed a possible kratom sales ban over health concerns, while a Bucks County judge barred a smoke shop from selling kratom to minors under 21. Tech & Identity Risk: FBI probes a dark-web ID verification breach after millions of driver’s license scans were reportedly sold, including medical-record-type data that could impact cannabis businesses. Health Research: An Oregon state-regulated psilocybin study linked supervised sessions to lower depression, anxiety, and PTSD with no serious adverse events. Cannabis in the Courts: A clemency move commuted federal marijuana sentences for two people as rescheduling advances. Drug Enforcement: Bridgeport raid reportedly seized fentanyl pills plus other drugs, including marijuana, and police expect more arrests.

Hemp THC Policy: Congress just approved a one-month delay of most federal hemp-derived THC restrictions, pushing the effective date from Nov. 12, 2026 to Dec. 11, 2026—while synthetic cannabinoids still face the original timeline. Regulatory Safety: Missouri regulators issued a recall for certain marijuana products made via chemical modification/conversion/synthetic derivation of cannabinoids, urging consumers to stop use and report adverse reactions. Product Liability/Enforcement: Colorado’s system is under fire after reports of a marijuana sleep aid causing liver injuries sat on shelves for over a year before formal safety warnings—highlighting slow consumer protection. Driving & Public Safety: A new study warns edible THC can impair driving performance even when blood THC stays below typical roadside legal cutoffs. Local Cannabis Market: Missouri also saw a DCR recall notice, while Minnesota opened a new dispensary in Steele County. Health Research: Studies linked trauma-related psychiatric disorders to higher later heart and stroke risk, and perimenopause research explored depression/cognitive signals using metabolic indices. Cannabis in the News Cycle: A judge issued an arrest warrant in a UK cannabis case, and separate reports covered marijuana seizures and enforcement actions.

Hemp THC policy pause: Congress and the White House moved to delay the federal hemp THC product ban, pushing key restrictions to Dec. 11 (from Nov. 12) and giving businesses a short runway to adjust instead of facing an immediate crackdown. Driving safety: A new study flags edible THC as a hidden road risk—drivers can show impaired lane control and slower reactions even when roadside blood tests stay under the usual legal cutoff. Sleep & CBD research: A clinical review reports cannabinoids may improve insomnia—faster sleep onset, longer duration, and better sleep continuity—with mostly mild, temporary side effects. Local cannabis access: Steele County, Minn. welcomed its first cannabis dispensary, Black Bear Dispensary, as owners aim to reduce stigma and serve local demand. Community health & policy: Virginia’s cannabis rollout is moving through local special-use permitting, with municipalities limited by state mandate as sales are slated for July 1, 2027. Public health enforcement: Nigeria Customs handed over billions in seized drugs, including synthetic cannabis, to NDLEA and environmental regulators.